|
Aug 5
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Aug 4
|
US WorldMeds Completes Acquisition of Adaptimmune's Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel
|
|
Aug 1
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Down Over 4% for Week
|
|
Jul 29
|
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
|
|
Jul 28
|
Sector Update: Health Care Stocks Retreat Late Afternoon
|
|
Jul 28
|
European Equities Fall in Monday Trading; EU Strikes Trade Deal With US
|
|
Jul 28
|
Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMeds
|
|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
|
Jul 24
|
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
|
|
Jun 26
|
General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls
|
|
May 7
|
Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025
|